[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus

Ying Xu1, Yajun Qian, Qin Gu

  • 1Department of Critical Care Medicine, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing 210000, Jiangsu, China. Corresponding author: Tang Jian,

Insights

Elevated D-dimer levels in COVID-19 patients correlate with increased inflammation and organ dysfunction. D-dimer can predict organ injury in coronavirus disease 2019 (COVID-19) patients.

Area of Science:

  • Biomedical research
  • Infectious disease pathology
  • Clinical diagnostics

Background:

  • Coronavirus disease 2019 (COVID-19) is associated with coagulopathy and systemic inflammation.
  • Understanding biomarkers for disease severity and organ damage is crucial for patient management.

Purpose of the Study:

  • To investigate the association between D-dimer levels and inflammatory markers.
  • To explore the relationship between D-dimer and organ function in COVID-19 patients.
  • To evaluate D-dimer's predictive value for organ injury.

Main Methods:

  • Retrospective analysis of 72 COVID-19 patients' clinical and laboratory data.
  • Comparison of inflammatory markers and cytokines between D-dimer normal and elevated groups.
  • Linear regression analysis for D-dimer correlation with organ function parameters.
  • Receiver operating characteristic (ROC) curve analysis to assess D-dimer's predictive performance for organ damage.

Main Results:

  • Elevated D-dimer levels were observed in 55.6% of patients and correlated with disease severity.
  • Patients with higher D-dimer showed increased inflammatory markers (WBC, NEU, PCT, hs-CRP, IL-6, IL-8, IL-2R, TNF-α) and impaired organ function (lower SpO2, PaO2/FiO2, PLT; higher RR, AST, TBil, DBil).
  • ROC analysis indicated D-dimer has good predictive value for organ injury (AUC=0.889), with a sensitivity of 85.7% and specificity of 78.1% at a cut-off of 2.36 mg/L.

Conclusions:

  • D-dimer levels are significantly associated with inflammatory status in COVID-19.
  • D-dimer correlates with multiple indicators of organ dysfunction in COVID-19 patients.
  • D-dimer serves as a valuable biomarker for predicting organ injury in COVID-19.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
204
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
317
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
425
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K